Urinary interleukin-18 as an early indicator to predict contrast-induced nephropathy in patients undergoing percutaneous coronary intervention
- PMID: 25187836
- PMCID: PMC4151647
- DOI: 10.3892/etm.2014.1898
Urinary interleukin-18 as an early indicator to predict contrast-induced nephropathy in patients undergoing percutaneous coronary intervention
Abstract
Contrast-induced nephropathy (CIN) is at present the third leading cause of hospital-acquired acute kidney injury (AKI). Traditionally, it is diagnosed by measuring an increase of the serum creatinine (SCr) concentration. However, SCr is an insensitive marker for detecting CIN. This study was designed to investigate whether human urinary interleukin-18 (IL-18) is early predictive marker for CIN following coronary interventional procedures. The general clinical data of 180 patients who underwent coronary interventional procedures at the Department of Cardiology, Affiliated Hospital of Xuzhou Medical College from March 1, 2012 to September 31, 2012 were collected. A nonionic, low osmolality contrast agent was used in the laboratory at this time. SCr values and estimated glomerular filtration rate (eGFR) were measured prior to and within 24 and 48 h after the administration of contrast agents. Urine samples were collected prior to and 2, 6, 12, 24 and 48 h after the coronary interventional procedure, and urinary IL-18 levels were measured using an ELISA kit. CIN was defined as an increase of ≥0.5 mg/dl or ≥25% in SCr concentration over baseline 24-48 h after the procedure. CIN occurred in 16 of 180 (8.9%) patients. The levels of urinary IL-18 measured 2 h after the procedure were increased in the CIN group, but the increase was not significant (P>0.05). There were significant differences (P<0.05) between the urinary IL-18 levels 6, 12, 24 and 48 h after the procedure and those before the procedure. No significant difference was identified between the SCr levels measured prior to and 24 h after the procedure. The area under the receiver operating characteristic (ROC) curve of urinary IL-18 12 h after the procedure was 0.811 and the 95% confidence interval of the area under the curve was 0.735-0.888. If the critical point of the diagnosis of CIN was 815.61 pg/ml, the sensitivity was 87.5% and the specificity was 62.2%. Univariate analysis indicated that the urinary IL-18 level was positively correlated with the SCr concentration pre- and postprocedure. In conclusion, urinary IL-18 may be a promising indicator for the early prediction of CIN.
Keywords: contrast-induced nephropathy; coronary artery angiography; interleukin-18.
Figures

Similar articles
-
Urinary kidney injury molecule-1 as an early indicator to predict contrast-induced acute kidney injury in patients with diabetes mellitus undergoing percutaneous coronary intervention.Biomed Rep. 2015 Jul;3(4):509-512. doi: 10.3892/br.2015.449. Epub 2015 Apr 16. Biomed Rep. 2015. PMID: 26171157 Free PMC article.
-
Urinary IL-18 and NGAL as early predictive biomarkers in contrast-induced nephropathy after coronary angiography.Nephron Clin Pract. 2008;108(3):c176-81. doi: 10.1159/000117814. Epub 2008 Feb 21. Nephron Clin Pract. 2008. PMID: 18287807 Clinical Trial.
-
Plasma neutrophil gelatinase-associated lipocalin (NGAL) as an early predictive marker of contrast-induced nephropathy in hospitalized patients undergoing computed tomography.Clin Kidney J. 2013 Dec;6(6):578-83. doi: 10.1093/ckj/sft109. Epub 2013 Aug 28. Clin Kidney J. 2013. PMID: 26069825 Free PMC article.
-
Prediction of contrast-induced nephropathy by the serum creatinine level on the day following cardiac catheterization.J Cardiol. 2016 Nov;68(5):412-418. doi: 10.1016/j.jjcc.2015.10.016. Epub 2015 Dec 18. J Cardiol. 2016. PMID: 26708123
-
Neutrophil gelatinase-associated lipocalin (NGAL): a promising biomarker of contrast-induced nephropathy after computed tomography.Ren Fail. 2014 Jul;36(6):979-86. doi: 10.3109/0886022X.2014.900429. Epub 2014 Mar 27. Ren Fail. 2014. PMID: 24673459 Review.
Cited by
-
The potential use of biomarkers in predicting contrast-induced acute kidney injury.Int J Nephrol Renovasc Dis. 2016 Sep 9;9:205-21. doi: 10.2147/IJNRD.S105124. eCollection 2016. Int J Nephrol Renovasc Dis. 2016. PMID: 27672338 Free PMC article. Review.
-
Renalase and Biomarkers of Contrast-Induced Acute Kidney Injury.Cardiorenal Med. 2015 Dec;6(1):25-36. doi: 10.1159/000439117. Epub 2015 Sep 19. Cardiorenal Med. 2015. PMID: 27194994 Free PMC article. Review.
-
Evaluation of safety and efficacy of elective PCI in patients with cardiac insufficiency.Exp Ther Med. 2017 Feb;13(2):609-613. doi: 10.3892/etm.2016.4005. Epub 2016 Dec 27. Exp Ther Med. 2017. PMID: 28352338 Free PMC article.
-
Association between Serum Ferritin and Contrast-Induced Nephropathy in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.Biomed Res Int. 2016;2016:5420345. doi: 10.1155/2016/5420345. Epub 2016 Jul 28. Biomed Res Int. 2016. PMID: 27547760 Free PMC article.
-
Biomarkers of Drug-Induced Kidney Toxicity.Ther Drug Monit. 2019 Apr;41(2):213-226. doi: 10.1097/FTD.0000000000000589. Ther Drug Monit. 2019. PMID: 30883514 Free PMC article. Review.
References
-
- Bartorelli AL, Marenzi G. Contrast-induced nephropathy. J Interv Cardiol. 2008;21:74–85. - PubMed
-
- Parfrey P. The clinical epidemiology of contrast-induced nephropathy. Cardiovasc Intervent Radiol. 2005;28(Suppl 2):S3–S11. - PubMed
-
- Mehran R, Nikolsky E. Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney Int Suppl. 2006;(100):S11–S15. - PubMed
-
- Hardy J, Hambly B, Ko H, et al. Stimulation of mesangial cells by angiotensin II and lipopolysaccharide increases expression of interleukin-18, but not IL-18 receptor. Nephron Exp Nephrol. 2010;116:e63–e71. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous